Rheumatoid Arthritis

      A bit of talk about treating pre-RA, but how do patients feel about it?

      Clinically suspect arthralgia pts, Leeds
      Influe

      David Liew drdavidliew

      1 year 10 months ago
      A bit of talk about treating pre-RA, but how do patients feel about it? Clinically suspect arthralgia pts, Leeds Influenced by different factors: symptoms personal risk meds experience knowledge perceived effort Acceptable tradeoffs are very personal #ACR23 ABST1258 @RheumNow https://t.co/wZGfdffNji
      The order of use will affect the safety and effectiveness of drug Rx in #Rheumatoid #arthritis So if #Rituximab is used

      Janet Pope

      1 year 10 months ago
      The order of use will affect the safety and effectiveness of drug Rx in #Rheumatoid #arthritis So if #Rituximab is used in later line #Rx - is looks worse@than ex #TNFi used early. Never forget prescribing bias / confounding the results. @RheumNow @ACRheum #ACR23 https://t.co/JJ8BY7n9VM
      #GreatDebate #ACR23 @RheumNow
      Advanced Rx 1st line in PMR/GCA
      @philseo
      IL-6 research in RA (STREAM, MOBILITY): safety

      Eric Dein

      1 year 10 months ago
      #GreatDebate #ACR23 @RheumNow Advanced Rx 1st line in PMR/GCA @philseo IL-6 research in RA (STREAM, MOBILITY): safety of toci, sarilumab - compares to ADA Ifn risk driven by GCs GUSTO: TCZ w/ only 3d GC pulse - 13/18 in remission 24, 52w PMR: "its not just a little bit of pred" https://t.co/sAlQ0pttcq
      Should #filgo be fil-gone in North America?
      Unfortunately #filgotinib is not in NA, but is elsewhere & expanding i

      Janet Pope

      1 year 10 months ago
      Should #filgo be fil-gone in North America? Unfortunately #filgotinib is not in NA, but is elsewhere & expanding into other diseases #IBD, IA, etc. Safety at >8yrs is similar to other #JAKi. #CDAI in MTX-IR at 1 yr in 200mg is impressive. @ACRheum @RheumNow #ACR23 1323, 1325 https://t.co/3iAZRcSeq6
      Towards Personalised Care in RA

      Since the millennium, we have seen an expansion in the number of advanced treatments bo

      Dr. John Cush RheumNow

      1 year 10 months ago
      Towards Personalised Care in RA Since the millennium, we have seen an expansion in the number of advanced treatments both biologic and targeted synthetic disease modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). #ACR23 https://t.co/SjyfMyPyGw https://t.co/uzG72vKSpd
      Conv3.jpg
      ACR23 – Day 1 Report
      1 year 10 months ago
      ACR 2023 is back in San Diego for its annual convergence of thousands of rheumatologists to partake, discover and learn from thousands of abstracts and hundreds of sessions and presentations. It was a big return for the Poster Hall with rows and rows of research, friends, fellows and poster tours.  Below are a few of my favorite presentations from the posters, Plenary and oral sessions on day one.
      male.female.sexist.jpg
      Sex bias in RA: time to stop blaming hormones?
      1 year 10 months ago
      Whether it’s RA, SLE or Sjogren’s, the increased prevalence of females affected by auto-immune diseases is well established, yet not fully understood. Often, I have heard that sexual hormones are responsible for every aspect of it. Two abstracts presented this year question this paradigm.
      ACR Best
      #ACR BEST Abstracts from San Diego – Day 1
      1 year 10 months ago
      The RheumNow faculty reporters have been scouring the meeting for what they believe to be the best presentations from the first day at ACR 2023 in San Diego.  From hundreds of online presentations, the poster floor and the plenary podium, here are some of the best abstracts from Sunday Nov. 12th. You can spot these on Twitter by looking for the (#ACRbest) hashtag.
      ABS0122 at #ACR23

      ⭐️Risk of acute MI, stroke & death signif ⬆️ among RA/SLE pts w/ depress, anxiety, &amp

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year 10 months ago
      ABS0122 at #ACR23 ⭐️Risk of acute MI, stroke & death signif ⬆️ among RA/SLE pts w/ depress, anxiety, &/or PTSD vs w/o both RA/SLE ➡️U.S. pts: 3825 RA, 1862 SLE --> 1790 w/ above mental health dz, no prior CVD ➡️HR 1.28 after adjusting for🚬, obesity, & comorbidities @RheumNow https://t.co/sXMFtaKmYB
      ABS0155 @ #ACR23

      Economic impact of switching from SQ MTX (Rasuvo) from oral MTX in U.S. RA pts?'

      ➡️ Rasuvo assoc

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year 10 months ago
      ABS0155 @ #ACR23 Economic impact of switching from SQ MTX (Rasuvo) from oral MTX in U.S. RA pts?' ➡️ Rasuvo associated with significantly higher all cause total expenditure $4704 predominantly due to higher costs associated tin all cause pharmacy utilization $4,223! @Rheumnow https://t.co/ry8XxjvHRg
      ABS0164 @ #ACR23

      Is a virtual MSK test consistent & comparable to in-person assessments w/ regard to dz activity i

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year 10 months ago
      ABS0164 @ #ACR23 Is a virtual MSK test consistent & comparable to in-person assessments w/ regard to dz activity in f/u of RA pts? YES! Some variability in # of swollen joints but approach shown below had good reliability & acceptable lvl of agreement @RheumNow #ACRBEST https://t.co/yxpPb2Br4n
      TM01 @ #ACR23: Daunting Case of Diarrhea

      65 yo F w/ sero+RA + 2ndary SjS p/w 4 wks diarrhea
      -CT a/p: thickening of cec

      Meral K. El Ramahi, MD MeralElRamahiMD

      1 year 10 months ago
      TM01 @ #ACR23: Daunting Case of Diarrhea 65 yo F w/ sero+RA + 2ndary SjS p/w 4 wks diarrhea -CT a/p: thickening of cecum, ascending colon -Colonoscopy path: ischemia -R colectomy: enterocoelic lymphocytic phlebitis, no underlying vasculitis. Dx: IgG4-RD, serum IgG4⬆️ @RheumNow https://t.co/jQ57U5EjPo
      1-Can we prevent RA ? Vagotomy?
      2-CV events in auto immune rheumatic disease pregnancies.
      3-CVS vasculitis , challenge

      Nouf Al hemmadi

      1 year 10 months ago
      1-Can we prevent RA ? Vagotomy? 2-CV events in auto immune rheumatic disease pregnancies. 3-CVS vasculitis , challenges and role of Brain biopsy And others…….. https://t.co/BX8bDSX1M3 @RheumNow , daily recap #ACR23
      20 years real-world data on disease burden, patient experience & unmet needs in Refractory #RheumatoidArthritis

      ▶

      Dr Ai Lyn Tan DrAiLynTan

      1 year 10 months ago
      20 years real-world data on disease burden, patient experience & unmet needs in Refractory #RheumatoidArthritis ▶️Higher glucocorticoid & opioid use ▶️Greater comorbidity & symptom burden ▶️More rheumatology visits #ACR23 👉🏽https://t.co/CAUorjQbvN by @KristinWipfler @Dr_K et al https://t.co/vx1aOZizfE
      OMG! The #Gerirheum community is looking into this bias— pls fill out their survey @UnaMakris @SattuiSEMD https://t.co

      TheDaoIndex KDAO2011

      1 year 10 months ago
      OMG! The #Gerirheum community is looking into this bias— pls fill out their survey @UnaMakris @SattuiSEMD https://t.co/Axaoo3WohH

      Podcasts

      • ACR Podcast - Day1A

      Catch up on Conference Podcasts

      ×